Kwangdong Healthbio Co., Ltd. (XKON:086220)

Market Cap	15.75B
Revenue (ttm)	38.10B
Net Income (ttm)	-323.52M
Shares Out	10.57M
EPS (ttm)	-57.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13
Average Volume	231
Open	1,599.00
Previous Close	1,589.00
Day's Range	1,595.00 - 1,599.00
52-Week Range	1,150.00 - 2,795.00
Beta	-0.11
RSI	48.78
Earnings Date	n/a

About Kwangdong Healthbio

Kwangdong Healthbio Co., Ltd. manufactures and sells functional health and general food, and cosmetic products. The company offers functional health food products for applications in the areas of intestines, immunity, blood circulation, cognitive ability improvement, cavity, blood sugar control, anti-oxidation, memory improvement, prostate health, fatigue improvement, joint/bone health, skin care, liver health, calcium absorption, cholesterol, blood pressure control, eye care, ergogenic ability improvement, body fat, neutral fat in blood, relax...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 81
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 086220

Financial Performance

In 2014, Kwangdong Healthbio's revenue was 38.10 billion, an increase of 19.85% compared to the previous year's 31.79 billion. Losses were -323.52 million, -15.02% less than in 2013.